It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have lost about 3.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue ...

Here are three reasons why there are better opportunities than HSIC and a stock we'd rather own. With a vast inventory of ...

One very interesting company for investors to keep in mind is none other than Henry Schein (NASDAQ:HSIC). For those not familiar the firm, it describes itself as a solutions company for ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein (NASDAQ:HSIC) in the last three months. The table below offers a condensed view ...

As you can see from the chart above the percentage of shares that are sold short for Henry Schein has declined since its last report. This does not mean that the stock is going to rise in the near ...

Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued to ...

Learn more about whether BrightSpring Health Services, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ ...

The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes ...

With its stock down 8.4% over the past month, it is easy to disregard Henry Schein (NASDAQ:HSIC). It seems that ...

Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.

MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting ...

Henry Schein Q4 Earnings Miss, Operating Margin Down Henry Schein registered adjusted earnings per share of 66 cents in the fourth quarter of 2023, down 51.1% from the year-ago period’s adjusted ...